Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: 64 year old female admitted with 2 week history of ruq pain worsening over last dayswith associated nausea, vomiting and diarrhea. patient went to outside hospital, ultrasound showed gallstones, ct showed gangrenous gallbladder. major surgical or invasive procedure: percutaneous cholecystotomy tube. history of present illness: 64 female with 2 week history of right upper quandrant pain with nausea, vomiting and diarrhea. admitted to where ultrasound shoed gallstones, ct showed gangrenous cholecystitis and pericholecystic abscess. patient had respiratory distress with associated with increased abdominal pain and was intubated for airway protection while percutaneous drain placed. past medical history: dm w/ neuropathy, htxn, cva ', morbid obesity, urinary incontinence, depression, umbo hernia social history: son reports that his brother, , lives with pt and other brother, , lives nearby. pt also has dtr in . reports that pt is, ??????stubborn??????, non-compliant with help as she will not let helpers into her home and has poor hygiene that family can't get her to pay attention to. family history: unknown physical exam: vital signs on temperature 102.8, hr 120, bp 194/94 rr 20 92% on ra. alert and orientated x 3 nad morbidly obese rrr s1, s2 clear to auscultation bilaterally abd. soft, non-distended, tender ruq, + pertinent results: 11:05pm blood wbc-28.6* rbc-4.80 hgb-13.1 hct-39.3 mcv-82 mch-27.3 mchc-33.4 rdw-14.9 plt ct-243 01:37am blood wbc-10.0# rbc-3.59* hgb-9.6* hct-29.2* mcv-81* mch-26.8* mchc-33.0 rdw-15.2 plt ct-163 01:02am blood wbc-14.6* rbc-4.01* hgb-10.8* hct-32.8* mcv-82 mch-27.0 mchc-33.0 rdw-15.9* plt ct-244 03:04pm blood wbc-15.0* rbc-3.91* hgb-10.1* hct-31.7* mcv-81* mch-25.9* mchc-32.0 rdw-15.6* plt ct-449* 02:29am blood wbc-19.3* rbc-3.62* hgb-9.8* hct-30.0* mcv-83 mch-27.0 mchc-32.7 rdw-16.4* plt ct-384 05:50am blood wbc-16.1* rbc-2.78* hgb-7.7* hct-23.5* mcv-85 mch-27.9 mchc-33.0 rdw-19.0* plt ct-436 11:05pm blood pt-14.4* ptt-31.3 inr(pt)-1.3* 02:01am blood pt-15.5* ptt-32.6 inr(pt)-1.4* 02:29am blood pt-15.4* ptt-30.8 inr(pt)-1.4* 11:05pm blood glucose-282* urean-16 creat-1.3* na-134 k-4.5 cl-99 hco3-21* angap-19 02:01am blood glucose-94 urean-25* creat-1.7* na-134 k-4.1 cl-103 hco3-23 angap-12 01:02am blood glucose-187* urean-32* creat-1.7* na-136 k-4.6 cl-105 hco3-23 angap-13 02:12am blood glucose-123* urean-30* creat-1.9* na-142 k-3.8 cl-105 hco3-31 angap-10 02:04am blood glucose-105 urean-49* creat-2.4* na-138 k-4.2 cl-104 hco3-28 angap-10 04:23am blood glucose-79 urean-99* creat-3.6* na-136 k-4.1 cl-106 hco3-17* angap-17 11:05pm blood alt-55* ast-30 alkphos-276* totbili-1.0 dirbili-0.3 indbili-0.7 07:19am blood alt-64* ast-125* ld(ldh)-283* alkphos-1120* totbili-6.3* 02:19am blood alt-49* ast-80* ld(ldh)-268* alkphos-897* amylase-84 totbili-7.6* dirbili-6.6* indbili-1.0 04:17am blood alt-16 ast-19 alkphos-450* totbili-2.1* dirbili-1.4* indbili-0.7 05:50am blood alt-14 ast-19 alkphos-319* amylase-49 totbili-1.6* 05:50am blood lipase-93* 02:09am blood calcium-8.3* phos-2.9 mg-2.5 01:34am blood albumin-2.3* calcium-8.5 phos-4.0 mg-2.0 iron-40 04:23am blood calcium-8.4 phos-5.4* mg-2.3 01:34am blood caltibc-224* ferritn-339* trf-172* 03:04pm blood d-dimer-3012* imaging: ruq us: decompressed gb, + non-obstructing stone cxr: minimal change from . small b pleural effusion ct abd: decreased size of gb colln, ? stone. bibasilar atelectasis with small bilateral pleural effusions. mild volume overload. ct head: chronic changes, no hemorrhage eeg: abnormal eeg due to the slow and disorganized background and bursts of generalized slowing. these findings indicate a widespread encephalopathy affecting both cortical and subcortical structures. medications, infxn, metabolic. there were no focal abnormalities, but encephalopathies may obscure focal findings. there were no epileptiform features. liver us - f/u liver duplex - vasculature patent, large gallstone, gb collapsed, wall edema, wall thickening; 1.5cm hypoechoic liver shadowing - gb wall vs. artifact ct a/p: incr ill-defined hyperdense collection surrounding decompressed gb, c/w hemorrhage, extends into the cbd, new intrahepatic bili ductal dilat concerning for obstruction ?due to clot vs stent malfunction. ng tube side port above ge junction--advance. exophytic lesion from l kidney, ? parenchymal lobulation. rec f/u abdominal ct in months to assess short term stability. cxr: improved l base w/mildly worse atelectasis at r base : extubated, hct 21 with elevated bun, 2u prbc : r uq us: gallbladder containing stone and echogenic material as well as echogenic material adjacent to the gallbladder, most compatible with hemorrhage. the appearance is not appreciably changed since the prior ct, allowing for differences in techniques micro: urine: >100k yeast 2 colonies micro urine: plenty rbc and loads of yeast bcx x 2 ngtd, ucx >10^5 yeast, cath tip neg bcx x 2 neg, ucx: yeast bile - 3+ gprs, 2+gnrs, no speciation ucx - s.aureus coag neg brief hospital course: events: patient admitted with ruq pain for 2 weeks, gangrenous cholecystitis per ct, kept npo, iv fluids and planned ptc drain. to icu for monitoring. intubated for tachypnea; ptc drain placed : extubated, off insulin drip : delirious : confused, hallucinating, pt d/ced perc drain, transfered to tsicu, intubated for airway protection. : eeg done, neuro consulted, extubated on bipap. : jaundice, wbc up to 15, tuberculosis:6.3, alk 1120--> today. intubated. started on vancomy and zosyn. - normal and 7cm by 10fr cotton biliary stent was placed given jaundice and suspicion for perforated gengenous gallbladder. central line changed; ef 70%, hepatic duplex us. tpn ordered. insulin gtt extubated : extubated, hct 21 with elevated bun, 2u prbc given. : r uq us: gallbladder containing stone and echogenic material as well as echogenic material adjacent to the gallbladder, most compatible with hemorrhage. the appearance is not appreciably changed since the prior ct, allowing for differences in techniques. patient found on floor. ct of head and ct of c-spine done - both ok. ruq ultrasound - showed 8 cm fluid collection around gallbladder. ptc drain replaced. - mental status clearing with little confusion now. eating diabetic diet without problems. consults: renal - related to high bun and creatinine. thought to be due to atn, hypotension related to sepsis. fluids restricted, lasix continued. bun and cre. plateaued and now trending down. neuro - - mental status changes consistent with a toxic-metabolic encephalopathy. psychiatry - delirium due to multiple medical conditions; depressive d/o nos, r/o bipolar disorder; r/o ptsd; r/o psychosis nos; will discharge to extended care facility with follow up for discontinuing of ptc drain and surgical care as needed. medications on admission: lasix 80', atenolol 50", norvasc 10', plavix 75', enalapril 20', bupropion 200am 100pm, lipitor 10', zoloft 100', lantus 70 am discharge medications: 1. heparin (porcine) 5,000 unit/ml solution sig: one (1) ml injection tid (3 times a day). 2. amlodipine 5 mg tablet sig: two (2) tablet po daily (daily). 3. atorvastatin 10 mg tablet sig: one (1) tablet po daily (daily). 4. acetaminophen 325 mg tablet sig: two (2) tablet po q6h (every 6 hours) as needed for fever. 5. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 6. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed. 7. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily) as needed. 8. atenolol 50 mg tablet sig: one (1) tablet po bid (2 times a day). 9. thiamine hcl 100 mg tablet sig: one (1) tablet po daily (daily). 10. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 11. bupropion 100 mg tablet sig: two (2) tablet po qam (once a day (in the morning)). 12. furosemide 80 mg tablet sig: one (1) tablet po daily (daily). 13. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution for nebulization sig: 1-2 puffs inhalation q6h (every 6 hours). 14. calcium acetate 667 mg capsule sig: two (2) capsule po tid w/meals (3 times a day with meals). 15. sodium citrate-citric acid 500-300 mg/5 ml solution sig: fifteen (15) ml po bid (2 times a day). 16. insulin regular human 100 unit/ml solution sig: one (1) unit/ml injection asdir (as directed). unit/ml 17. epoetin alfa 2,000 unit/ml solution sig: .5 ml injection qmowefr (monday -wednesday-friday). discharge disposition: extended care facility: medical center - discharge diagnosis: primary diagnosis: cholesystitis with sepsis secondary diagnosis: renal failure discharge condition: stable. discharge instructions: please call your doctor or return to the emergency room if you have any of the following: * you experience new chest pain, pressure, squeezing or tightness. * new or worsening cough or wheezing. * if you are vomiting and cannot keep in fluids or your medications. * you are getting dehydrated due to continued vomiting, diarrhea or other reasons. signs of dehydration include dry mouth, rapid heartbeat or feeling dizzy or faint when standing. * you see blood or dark/black material when you vomit or have a bowel movement. * you have shaking chills, or a fever greater than 101.5 (f) degrees or 38(c) degrees. * any serious change in your symptoms, or any new symptoms that concern you. * please resume all regular home medications and take any new meds as ordered. wound care: you may shower, no tub baths or swimming. monitor ptc drain and keep area around it clean and dry. followup instructions: provider: 2 (st-4) gi rooms date/time: 8:00 provider: , md phone: date/time: 8:00 provider: . , (surgeon) please call for follow up appointment regarding possible surgery on your gallbladder at . procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours venous catheterization, not elsewhere classified venous catheterization, not elsewhere classified venous catheterization, not elsewhere classified continuous invasive mechanical ventilation for 96 consecutive hours or more continuous invasive mechanical ventilation for 96 consecutive hours or more parenteral infusion of concentrated nutritional substances insertion of endotracheal tube insertion of endotracheal tube insertion of endotracheal tube hemodialysis venous catheterization for renal dialysis other bronchoscopy arterial catheterization endoscopic insertion of stent (tube) into bile duct transfusion of packed cells percutaneous aspiration of gallbladder percutaneous aspiration of gallbladder artificial pacemaker rate check diagnoses: obstructive sleep apnea (adult)(pediatric) acute kidney failure with lesion of tubular necrosis toxic encephalopathy unspecified septicemia iron deficiency anemia secondary to blood loss (chronic) severe sepsis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other chronic pulmonary heart diseases polyneuropathy in diabetes depressive disorder, not elsewhere classified chronic kidney disease, unspecified acute respiratory failure disorders of phosphorus metabolism long-term (current) use of insulin septic shock morbid obesity retention of urine, unspecified fitting and adjustment of cardiac pacemaker urinary incontinence, unspecified calculus of gallbladder with acute cholecystitis, without mention of obstruction umbilical hernia without mention of obstruction or gangrene volume depletion, unspecified diabetes with neurological manifestations, type ii or unspecified type, uncontrolled jaundice, unspecified, not of newborn ulcer of lower limb, unspecified perforation of gallbladder 

Answer: The patient is high likely exposed to